Exchange: NASDAQ·Updated 04:30 PM EDT
News
all
press releases
Wall Street Analysts Predict a 31.48% Upside in AtaiBeckley Inc (ATAI): Here's What You Should Know
The mean of analysts' price targets for AtaiBeckley Inc (ATAI) points to a 31.5% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Zacks
More News
LLY Q2 Earnings Top, GLP-1 Drugs Fuel Growth, Sales Guidance Raised
LLY crushes Q2 earnings estimates and lifts its 2026 sales outlook as Mounjaro and Zepbound fuel strong revenue growth and newer drugs add momentum.
Zacks
Are SOLS, LXP, ATAI Obtaining Fair Deals for their Shareholders?
Are SOLS, LXP, ATAI Obtaining Fair Deals for their Shareholders? Are SOLS, LXP, ATAI Obtaining Fair Deals for their Shareholders? PR Newswire NEW YORK, Aug. 4, 2026 Insiders may stand to receive substantial financial benefits not available to ordinary shareholders. The proposed transactions may...
PR Newswire
Will Mounjaro & Zepbound Drive Lilly's Q2 Results: Buy, Sell or Hold?
LLY is set to report Q2 results on Aug. 5, with GLP-1 drugs expected to drive growth as investors watch Foundayo's early sales.
Zacks
Missed AI, Memory Bull Run? Biotech May Be The Next Breakout Trade — But Retail Sentiment Has Never Been Lower
Drugmakers have announced 37 biotech acquisitions worth at least $1 billion this year, topping the previous annual record.
Stocktwits
How Much Upside is Left in AtaiBeckley Inc (ATAI)? Wall Street Analysts Think 33.33%
The consensus price target hints at a 33.3% upside potential for AtaiBeckley Inc (ATAI). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Zacks
Are PSNL, LXP, DSGR, ATAI Obtaining Fair Deals for their Shareholders?
Are PSNL, LXP, DSGR, ATAI Obtaining Fair Deals for their Shareholders? Are PSNL, LXP, DSGR, ATAI Obtaining Fair Deals for their Shareholders? PR Newswire NEW YORK, July 21, 2026 Insiders may stand to receive substantial financial benefits not available to ordinary shareholders. The proposed...
PR Newswire
GLP-1 Titans Clash: Comparing Eli Lilly and Novo Nordisk
LLY's leadership in obesity drugs, expanding pipeline and stronger growth outlook set it apart as investors weigh it against NVO in 2026.
Zacks
Billions Flow Into Next-Generation Depression Treatments as Pharma Innovation Accelerates
Billions Flow Into Next-Generation Depression Treatments as Pharma Innovation Accelerates Billions Flow Into Next-Generation Depression Treatments as Pharma Innovation Accelerates PR Newswire NEW YORK, July 21, 2026 Major Depressive Disorder Market Poised for Strong Growth as New Drug Innovations...
PR Newswire
ATAI Stock Downgraded Across Wall Street – Why Analysts Believe Buyout By Eli Lilly Capped Near-Term Upside
H.C. Wainwright and Berenberg became the latest firms to downgrade the stock following Eli Lilly's acquisition agreement.
Stocktwits

Advertisement|Remove ads.